Daisuke Wada

1.4k total citations
58 papers, 1.0k citations indexed

About

Daisuke Wada is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Daisuke Wada has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Daisuke Wada's work include Anesthesia and Sedative Agents (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Receptor Mechanisms and Signaling (5 papers). Daisuke Wada is often cited by papers focused on Anesthesia and Sedative Agents (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Receptor Mechanisms and Signaling (5 papers). Daisuke Wada collaborates with scholars based in Japan, United States and United Kingdom. Daisuke Wada's co-authors include Denham S. Ward, Sven Björkman, Donald R. Stanski, Jaap W. Mandema, William F. Ebling, David R. Drover, Hideyoshi Harashima, Sandra R. Harapat, Göran Benoni and Jörn Lötsch and has published in prestigious journals such as Journal of Clinical Oncology, Brain Research and European Heart Journal.

In The Last Decade

Daisuke Wada

52 papers receiving 970 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daisuke Wada Japan 19 193 180 171 151 145 58 1.0k
Naoki Kotani Japan 28 261 1.4× 444 2.5× 304 1.8× 213 1.4× 215 1.5× 92 2.2k
Michael J. Fossler United States 22 150 0.8× 255 1.4× 135 0.8× 87 0.6× 371 2.6× 69 1.5k
Satoshi Asai Japan 24 37 0.2× 262 1.5× 192 1.1× 171 1.1× 628 4.3× 143 1.8k
John Posner United Kingdom 26 42 0.2× 197 1.1× 386 2.3× 275 1.8× 302 2.1× 80 2.0k
R Arendt Germany 21 122 0.6× 278 1.5× 291 1.7× 102 0.7× 256 1.8× 59 1.5k
Shahram Taheri Iran 17 251 1.3× 162 0.9× 83 0.5× 40 0.3× 199 1.4× 66 1.2k
Peter Zannikos United States 19 71 0.4× 84 0.5× 59 0.3× 204 1.4× 215 1.5× 57 1.0k
A. Darragh Ireland 19 77 0.4× 64 0.4× 71 0.4× 126 0.8× 182 1.3× 71 1.1k
Shuzo Oshita Japan 20 187 1.0× 372 2.1× 228 1.3× 23 0.2× 364 2.5× 103 1.6k

Countries citing papers authored by Daisuke Wada

Since Specialization
Citations

This map shows the geographic impact of Daisuke Wada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Wada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Wada more than expected).

Fields of papers citing papers by Daisuke Wada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Wada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Wada. The network helps show where Daisuke Wada may publish in the future.

Co-authorship network of co-authors of Daisuke Wada

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Wada. A scholar is included among the top collaborators of Daisuke Wada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Wada. Daisuke Wada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mori, Hiroyoshi, Takahiro Tezuka, Daisuke Wada, et al.. (2024). Use of Direct Oral Anticoagulation for Isolated Distal Deep Vein Thrombosis in Japanese Orthopedic Patients. Annals of Vascular Diseases. 17(4). 371–377.
2.
Mori, Hiroyoshi, et al.. (2020). Does a Drug-Coated Balloon Accelerate Neoatherosclerosis?. CJC Open. 2(4). 306–307. 1 indexed citations
3.
Quartino, Angelica, Hanbin Li, Whitney P. Kirschbrown, et al.. (2018). Population pharmacokinetic and covariate analyses of intravenous trastuzumab (Herceptin®), a HER2-targeted monoclonal antibody, in patients with a variety of solid tumors. Cancer Chemotherapy and Pharmacology. 83(2). 329–340. 27 indexed citations
4.
Budha, Nageshwar, Maya K. Leabman, Jin Y. Jin, et al.. (2015). Modeling and Simulation to Support Phase 2 Dose Selection for RG7652, a Fully Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9. The AAPS Journal. 17(4). 881–890. 15 indexed citations
5.
Kurata, Tomoko, Daisuke Wada, Kazunori Miyazaki, et al.. (2014). Long-term Effect of Telmisartan on Alzheimer’s Amyloid Genesis in SHR-SR After tMCAO. Translational Stroke Research. 6(2). 107–115. 26 indexed citations
6.
Kurata, Tomoko, Daisuke Wada, Kazunori Miyazaki, et al.. (2014). Telmisartan Reduces Progressive Accumulation of Cellular Amyloid Beta and Phosphorylated Tau with Inflammatory Responses in Aged Spontaneously Hypertensive Stroke Resistant Rat. Journal of Stroke and Cerebrovascular Diseases. 23(10). 2580–2590. 34 indexed citations
7.
Garg, Amit, Angelica Quartino, Jing Li, et al.. (2014). Population pharmacokinetic and covariate analysis of pertuzumab, a HER2-targeted monoclonal antibody, and evaluation of a fixed, non-weight-based dose in patients with a variety of solid tumors. Cancer Chemotherapy and Pharmacology. 74(4). 819–829. 49 indexed citations
8.
Salazar, Daniel E., Jingpu Shi, Shashank Rohatagi, et al.. (2011). The Use of Modeling and Simulation to Guide Clinical Development of Olmesartan Medoxomil in Pediatric Subjects. Clinical Pharmacology & Therapeutics. 91(2). 250–256. 8 indexed citations
9.
Ogasawara, Takashi, et al.. (2009). A CASE OF ADENOENDOCRINE CELL CARCINOMA OF THE ILEUM. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 70(11). 3360–3365.
10.
Yamasaki, Yuki, Shigeki Nishihara, Hiroshi Mizuguchi, et al.. (2008). Protective effect against Parkinson's disease-related insults through the activation of XBP1. Brain Research. 1257. 16–24. 117 indexed citations
11.
Gao, Yuying, et al.. (2005). Population Pharmacokinetics of Olmesartan Following Oral Administration of its Prodrug, Olmesartan Medoxomil. Clinical Pharmacokinetics. 44(12). 1329–1342. 27 indexed citations
12.
Lemmens, Hendrikus J. M., Daisuke Wada, Catherine Munera, Ahmed El‐Tahtawy, & Donald R. Stanski. (2005). Enriched analgesic efficacy studies: An assessment by clinical trial simulation. Contemporary Clinical Trials. 27(2). 165–173. 22 indexed citations
13.
Björkman, Sven, et al.. (2001). Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model. Journal of Pharmaceutical Sciences. 90(9). 1226–1241. 59 indexed citations
14.
Wada, Daisuke, David R. Drover, & Harry J. M. Lemmens. (1998). Determination of the Distribution Volume that can be Used to Calculate the Intravenous Loading Dose. Clinical Pharmacokinetics. 35(1). 1–7. 29 indexed citations
15.
Wada, Daisuke, et al.. (1997). Computer Simulation of the Effects of Alterations in Blood Flows and Body Composition on Thiopental Pharmacokinetics in Humans . Anesthesiology. 87(4). 884–899. 63 indexed citations
16.
Harashima, Hideyoshi, William F. Ebling, Daisuke Wada, & Donald R. Stanski. (1997). No effect of age on the dose requirement of thiopental in the rat. Experimental Gerontology. 32(3). 315–324. 2 indexed citations
17.
Takagi, Toshihide, Manabu Sakai, Takamasa Ohnishi, et al.. (1996). Clinical Studies on the Factors of Massive Ascites in Early Postoperative Stage Following Hepatectomy for Hepatocellular Carcinoma.. The Japanese Journal of Gastroenterological Surgery. 29(7). 1636–1642. 1 indexed citations
18.
Ishikawa, Masashi, et al.. (1995). A Study of Operative Treatment for Hepatocellular Carcinoma with Special Reference to Recurrence after Surgery.. The Japanese Journal of Gastroenterological Surgery. 28(8). 1780–1787. 1 indexed citations
19.
Björkman, Sven, Donald R. Stanski, Hideyoshi Harashima, et al.. (1993). Tissue distribution of fentanyl and alfentanil in the rat cannot be described by a blood flow limited model. Journal of Pharmacokinetics and Biopharmaceutics. 21(3). 255–279. 46 indexed citations
20.
Kunitomo, Kazufumi, et al.. (1993). Case report of an anomalous arrangement of the pancreaticobiliary ducts and nuclear DNA ploidy analysis. Surgery Today. 23(2). 167–171. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoki Kotani Breakdown of academic impact, for papers by Michael J. Fossler Breakdown of academic impact, for papers by Satoshi Asai Breakdown of academic impact, for papers by John Posner Breakdown of academic impact, for papers by R Arendt Breakdown of academic impact, for papers by Shahram Taheri Breakdown of academic impact, for papers by Peter Zannikos Breakdown of academic impact, for papers by A. Darragh Breakdown of academic impact, for papers by Shuzo Oshita
Rankless by CCL
2026